Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (12): 1207-1208.DOI: 10.3969/j.issn.1673-8640.2022.12.022
Received:2022-02-23
Revised:2022-06-12
Online:2022-12-30
Published:2023-02-02
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.12.022
| 抗菌药物 | 病例1 | 病例2 | |||
|---|---|---|---|---|---|
| MIC | 结果 | MIC | 结果 | ||
| 青霉素 | ≤0.06 | 敏感 | >16 | 耐药 | |
| 头孢曲松 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 美罗培南 | ≤0.25 | 敏感 | ≤0.25 | 敏感 | |
| 万古霉素 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 红霉素 | ≤0.25 | 敏感 | ≥8 | 耐药 | |
| 环丙沙星 | ≤0.25 | 敏感 | ≤0.25 | 敏感 | |
| 四环素 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 复方磺胺甲噁唑 | ≤0.5/9.5 | 敏感 | ≤0.5/9.5 | 敏感 | |
| 利福平 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 利奈唑胺 | ≤2 | 敏感 | ≤2 | 敏感 | |
| 喹奴普丁-达福普丁 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 氯霉素 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 庆大霉素 | ≤4 | 敏感 | ≤4 | 敏感 | |
| 抗菌药物 | 病例1 | 病例2 | |||
|---|---|---|---|---|---|
| MIC | 结果 | MIC | 结果 | ||
| 青霉素 | ≤0.06 | 敏感 | >16 | 耐药 | |
| 头孢曲松 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 美罗培南 | ≤0.25 | 敏感 | ≤0.25 | 敏感 | |
| 万古霉素 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 红霉素 | ≤0.25 | 敏感 | ≥8 | 耐药 | |
| 环丙沙星 | ≤0.25 | 敏感 | ≤0.25 | 敏感 | |
| 四环素 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 复方磺胺甲噁唑 | ≤0.5/9.5 | 敏感 | ≤0.5/9.5 | 敏感 | |
| 利福平 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 利奈唑胺 | ≤2 | 敏感 | ≤2 | 敏感 | |
| 喹奴普丁-达福普丁 | ≤1 | 敏感 | ≤1 | 敏感 | |
| 氯霉素 | ≤0.5 | 敏感 | ≤0.5 | 敏感 | |
| 庆大霉素 | ≤4 | 敏感 | ≤4 | 敏感 | |
| 1 |
FUNKE G, STUBBS S, ALTWEGG M, et al. Turicella otitidis gen. nov.,sp. nov.,a coryneform bacterium isolated from patients with otitis media[J]. Int J Syst Bacteriol, 1994, 44(2):270-273.
DOI URL |
| 2 | Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated of fastidious bacteria[S]. M45,CLSI, 2011. |
| 3 |
BRINKROLF K, SCHNEIDER J, KNECHT M, et al. Draft genome sequence of Turicella otitidis ATCC51513,isolated from middle ear fluid from a child with otitis medis[J]. J Bacteriol, 2012, 194(21):5968-5969.
DOI URL |
| 4 |
JEZIORSKI E, MARCHANDIN H, JEAN-PIERRE H, et al. Turicella otitidis infection:otitis media complicated by mastoiditis[J]. Arch Pediatr, 2009, 16(3):243-247.
DOI URL |
| 5 | LI D, SHAN W, DAI C, et al. Bacteremia caused by Turicella otitidis in a patient with diffuse large b-cell lymphoma[J]. Clin Lab, 2020, 66(3). |
| 6 |
PRIYADARSHINI S R, BEHERA H S, SAHU S, et al. Turicella otitidis:a rare agent causing microbial keratitis[J]. BMJ Case Rep, 2021, 14(7):e241371.
DOI URL |
| 7 | FERNÁNDEZ PÉREZ A, PALOP BORRÁS B, MORENO LEÓN J A, et al. Cervical abscess due to Turicella otitidis[J]. Acta Otorrinolaringol Esp, 1999, 50(4):333-335. |
| 8 | KOUMAKI D, KOUMAKI V, BOUMPOUCHEROPOULOS S, et al. Turicella otitidis as an unusual agent causing palmoplantar eczema:an emerging pathogen[J]. Eur J Case Rep Intern Med, 2020, 7(2):001458. |
| 9 |
BAEK I, KIM M, LEE I, et al. Phylogeny trumps chemotaxonomy:a case study involving Turicella otitidis[J]. Front Microbiol, 2018, 9:834.
DOI URL |
| 10 |
LAPPAN R, JAMIESON S E, PEACOCK C S. et al. Reviewing the pathogenic potential of the otitis-associated bacteria Alloiococcus otitidis and Turicella otitidis[J]. Front Cell Infect Microbiol, 2020, 10:51.
DOI URL |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
